Molecular Partners
MOLN
7 hedge funds and large institutions have $5.73M invested in Molecular Partners in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
2% more capital invested
Capital invested by funds: $5.6M → $5.73M (+$129K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 2.58% → 2.56% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.74K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.8K |
MOLN Hedge Fund Activity: Q2 2023 in Review
7 of the 6,382 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q2 2023, worth a combined $5.73M — up 2.3% from $5.6M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MOLN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $9.74K. The largest seller was Susquehanna International Group, cutting an estimated $16.8K.
- 7 institutional investors held Molecular Partners (MOLN) as of Q2 2023, up from 6 in Q1 2023.
- Funds reported $5.73M of Molecular Partners stock for Q2 2023, up 2.3% quarter-over-quarter.
- 1 fund opened new Molecular Partners positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Molecular Partners buyer in Q2 2023 was Tang Capital Management, an estimated $9.74K added.
- The largest Molecular Partners seller in Q2 2023 was Susquehanna International Group, an estimated $16.8K sold.
Based on aggregated 13F filings for Q2 2023.